Biotech News
AtriCure to Participate in the 2026 Bank of America Securities Health Care Conference
MASON, Ohio --(BUSINESS WIRE)--Apr. 28, 2026-- AtriCure, Inc. ( Nasdaq: ATRC), a leading innovator in surgical treatments and therapies for atrial fibrillation (Afib), left atrial appendage (LAA) management, and post-operative pain management, today announced that the company will be participating
